Reviews

Combining sorafenib with chemoembolization for hepatocellular cancer


 

FROM THE FEDERAL REGISTER

ABOUT THE AUTHORS

Affiliations: Dr. Choi is Assistant Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. Dr. Critchfield is Assistant Professor of Radiology and Chief of Interventional Oncology, Detroit Medical Center, Wayne State University School of Medicine, Detroit, MI. Dr. Philip is Professor of Medicine, Wayne State University School of Medicine, and Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI. Conflicts of interest: The authors have no conflicts of interest to disclose.

1 Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, and 2 Department of Radiology, Section of Interventional Radiology, Detroit Medical Center, Wayne State University School of Medicine, Detroit, MI

Pages

Recommended Reading

Panel Backs Everolimus for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
Laparoscopic Hepatic Resection Found Safe For HCC Patients With Cirrhosis
MDedge Hematology and Oncology
Robotic Techniques Show Promise for Pancreatic Procedures
MDedge Hematology and Oncology
Early Results Promising for Robotic Pancreatic Resection
MDedge Hematology and Oncology
Everolimus Gets Nod for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
Tumor Necrosis After Chemotherapy May Predict Survival in Hepatoblastoma
MDedge Hematology and Oncology
Two Factors Predict Postradiotherapy Swallowing Difficulties
MDedge Hematology and Oncology
Low-Dose Irradiation Allays 93% of Gastric MALT Lymphomas at 10 Years
MDedge Hematology and Oncology
Sutent Approved for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology